Medicines Co. gets FDA approval of first patient-controlled patch for postoperative pain

The Medicines Company ($MDCO) scored two drug delivery feats on Friday. The FDA approved the company's Ionsys, making it the first patient-controlled patch for postoperative pain. In addition, the FDA approved the Medicine Company's Raplixa, the first spray powdered fibrin surgical sealant. More from FierceMedicalDevices

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.